Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
2.
Transfus Apher Sci ; 63(2): 103877, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38242725

ABSTRACT

Leprosy (i.e., Hansen's disease) is a chronic disease secondary to infection with either Mycobacterium leprae or M. lepromatosis. While the incidence of this disease is decreasing across the world, there is mounting evidence that it might be increasing, and becoming endemic, in the United States. Leprosy was once considered a potential threat to the blood supply, and while this threat has not borne out, it is worth revisiting the available data to assess whether it may pose a threat in the future. Herein, we discuss the evidence for and against the potential for transfusion-transmission of leprosy, and highlight future areas of research to further elucidate this possibility.


Subject(s)
Leprosy , Humans , United States/epidemiology , Incidence , Leprosy/epidemiology , Mycobacterium leprae
4.
Clin Dermatol ; 42(1): 25-37, 2024.
Article in English | MEDLINE | ID: mdl-37582453

ABSTRACT

The ocular and periocular manifestations of sexually transmitted infections are heterogeneous in etiology, manifestations, and complications. Etiologic agents include bacteria, viruses, parasites, and protozoa, which are most frequently transmitted via direct ocular contact with an active lesion or infected bodily fluid, autoinoculation, or dissemination from a distant site. Vertical transmission most commonly occurs perinatally during vaginal delivery. The complications of ophthalmia neonatorum can be severe, with the potential for permanent blindness or life-threatening systemic involvement if untreated. Clinical features, diagnostic modalities, and therapeutic regimens vary based on etiology and are summarized in this review. Prompt diagnosis is imperative, given the severe sequelae that may result from ocular involvement in these infections, including permanent vision loss. A multidisciplinary approach, involving both ophthalmology and dermatology, to diagnosis and management is essential to mitigate the risk of morbidity associated with sexually transmitted infections resulting in eye disease.


Subject(s)
HIV Infections , Ophthalmia Neonatorum , Ophthalmology , Sexually Transmitted Diseases , Infant, Newborn , Female , Humans , Sexually Transmitted Diseases/complications , Sexually Transmitted Diseases/diagnosis , Sexually Transmitted Diseases/epidemiology , Ophthalmia Neonatorum/etiology , Eye , HIV Infections/complications
6.
Clin Dermatol ; 2023 Oct 17.
Article in English | MEDLINE | ID: mdl-37858780

ABSTRACT

The ocular and periocular manifestations of sexually transmitted infections (STIs) are heterogeneous in etiology, manifestations, and complications. Etiologic agents include bacteria, viruses, parasites, and protozoa, which are most frequently transmitted via direct ocular contact with an active lesion or infected bodily fluid, autoinoculation, or dissemination from a distant site. Vertical transmission most commonly occurs perinatally during vaginal delivery. The complications of ophthalmia neonatorum can be severe with the potential for permanent blindness or life-threatening systemic involvement if untreated. Clinical features, diagnostic modalities, and therapeutic regimens vary based on etiology and are summarized in this review. Prompt diagnosis is imperative, given the severe sequelae that may result from ocular involvement in these infections, including permanent vision loss. A multidisciplinary approach, involving both ophthalmology and dermatology, to diagnosis and management is essential to mitigate the risk of morbidity associated with STIs resulting in eye disease.

8.
Cutis ; 112(1): 11-27, 2023 07.
Article in English | MEDLINE | ID: mdl-37611313
10.
BMJ ; 381: e074968, 2023 05 17.
Article in English | MEDLINE | ID: mdl-37197781

ABSTRACT

OBJECTIVE: To determine whether gender and racial inequities exist among Lasker Award recipients. DESIGN: Observational, cross sectional analysis. SETTING: Population based study. PARTICIPANTS: Recipients of four Lasker Awards from 1946 to 2022. MAIN OUTCOME MEASURES: Gender and race (non-white categorized as racialized v white categorized as non-racialized) of all Lasker Award recipients. Personal characteristics of award recipients were categorized by four independent authors using previously established methods and consistency of categorization among authors was analyzed. Women and non-white people were thought to be underrepresented among Lasker Award recipients compared with professional degree recipients overall. RESULTS: Among 397 Lasker Award recipients since 1946, 92.2% (366/397) were men. Most award recipients were identified as white (95.7%, 380/397). One non-white woman was identified as having received a Lasker Award over the course of seven decades. The proportion of women among award recipients in the most recent decade (2013-22) is similar to the first decade of awards (1946-55; 15.6%, 7/45 v 12.9%, 8/62). The median timeframe from terminal degree receipt to Lasker Award conferral for all award recipients is 30 years. The proportion of women who received a Lasker Award between 2019 and 2022 (7.1%) was less than would be expected based on the proportion of life science doctorates awarded to womenin 1989 (30 years previously; 38.1%). CONCLUSIONS: The number of women and non-white people in academic medicine and biomedical research continues to increase, yet the proportion of women among Lasker Award recipients has not changed in more than 70 years. Additionally, time from terminal degree receipt to Lasker Award conferral does not appear to fully account for the observed inequities. These findings establish the need for further investigation of possible factors that could hinder women and non-white people from entering the pool of eligible award recipients, potentially limiting the diversification of the science and academic biomedical workforce.


Subject(s)
Awards and Prizes , Biomedical Research , Medicine , Male , Humans , Female , Cross-Sectional Studies , Workforce
12.
Curr Med Res Opin ; 39(3): 383-386, 2023 03.
Article in English | MEDLINE | ID: mdl-36748834

ABSTRACT

OBJECTIVES: Although diversity, equity, and inclusion (DEI) initiatives are progressively being implemented across various arenas in academic medicine, biomedical research, and healthcare, significant inequities throughout medicine and biomedical research remain. One means by which to rectify these long-standing inequities is through the implementation of a position dedicated to DEI among journal editorial boards; thus, we sought to assess the extent to which this position has been implemented among high-impact biomedical research journals. METHODS: We performed a cross-sectional analysis of the editorial boards of the top 100 journals by impact factor (IF) across 30 medical specialties. All editorial board positions (editors-in-chief, deputy, associate, and assistant editors, as well as editorial and advisory board members) were included. We also assessed the proportion of other named-position editors (i.e. social media and statistics editors), and compared these to the proportion of DEI editors. RESULTS: Among the 100 highest IF biomedical journals (range: 12.035-508.702), 6 (6%) have a DEI editorial position. In contrast, 25 (25%) and 35 (35%) journals have at least 1 social media or statistics editorial position, respectively. The DEI editorial position comprises 0.086% of the 6974 total editorial positions, while social media (60/6974) and statistical (196/6974) editors comprise 0.86% and 2.81% of total journal editorial board positions, respectively. CONCLUSIONS: Few of the most influential biomedical journals have implemented a formal, named position dedicated to DEI. Biomedical journals should consider establishing a dedicated DEI editorial position, and ensure this individual position is publicly denoted on the editorial board.


Subject(s)
Medicine , Periodicals as Topic , Humans , Cross-Sectional Studies , Diversity, Equity, Inclusion
14.
J Dermatolog Treat ; 33(8): 3188-3190, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36000959

ABSTRACT

BACKGROUND: Acne can be a highly debilitating disease. There is a high prevalence in adults, yet treatment rates in this population are low. OBJECTIVES: An online survey was created to determine the main reasons why adults with acne do not seek treatment. METHODS: University students and staff 20 years of age and older were emailed a link to an online survey that asked them if they have facial acne, if they see a provider for it, and how they self-treat their acne. RESULTS: 1,136 complete surveys were returned. Top reasons for not seeing a provider include not being bothered enough to seek treatment (n = 418, 53.7%), believing that their acne will eventually resolve on its own (n = 351, 45.1%), concerned about costs of treatment (n = 274, 35.2%), and currently satisfied with over-the-counter (OTC) treatment (n = 261, 33.5%). CONCLUSION: Most adults with acne do not see providers because they are not bothered enough by it or are satisfied with OTC treatments. However, of the population that has acne and does not seek treatment, a significant portion (n = 234, 30.1%) indicated it was for a reason that could be classified as a treatment barrier.


Subject(s)
Acne Vulgaris , Humans , Adult , Universities , Acne Vulgaris/drug therapy , Surveys and Questionnaires , Students
16.
J Am Acad Dermatol ; 87(1): 1-18, 2022 07.
Article in English | MEDLINE | ID: mdl-35202775

ABSTRACT

The management of connective tissue diseases is dramatically evolving with the advent of biologics and novel oral systemic therapeutics. Despite involvement in the care of these complex patients, there is a knowledge gap in the field of dermatology regarding these emerging agents. The first article in this continuing medical education series discusses new and emerging therapeutics for lupus erythematosus and Sjögren syndrome that target cells, intracellular signaling pathways, and cytokines.


Subject(s)
Biological Products , Connective Tissue Diseases , Lupus Erythematosus, Systemic , Sjogren's Syndrome , Connective Tissue Diseases/therapy , Humans , Lupus Erythematosus, Systemic/complications , Lupus Erythematosus, Systemic/drug therapy , Sjogren's Syndrome/complications , Sjogren's Syndrome/drug therapy
17.
J Am Acad Dermatol ; 87(1): 21-38, 2022 07.
Article in English | MEDLINE | ID: mdl-35202777

ABSTRACT

The management of connective tissue diseases is dramatically evolving with the advent of biologics and novel oral systemic therapeutics. Despite involvement in the care of these complex patients, there is a knowledge gap in the field of dermatology regarding these emerging agents. The second article in this continuing medical education series discusses new and emerging therapeutics for dermatomyositis and scleroderma that target cells, intracellular signaling pathways, and cytokines.


Subject(s)
Connective Tissue Diseases , Dermatomyositis , Scleroderma, Localized , Scleroderma, Systemic , Connective Tissue Diseases/therapy , Dermatomyositis/drug therapy , Humans , Scleroderma, Localized/drug therapy , Scleroderma, Systemic/therapy
20.
Pediatr Dermatol ; 38(6): 1586-1587, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34725852

ABSTRACT

Trachyonychia (or twenty-nail dystrophy) is an uncommon chronic disorder manifesting as thin, flattened, brittle nails with excessive longitudinal ridging and loss of luster creating a "sandpaper-like" texture that most commonly presents spontaneously in childhood as an isolated phenomenon; however, it has been historically associated with numerous dermatoses. Rarely, trachyonychia has been reported to occur in families, suggesting a potential hereditary predisposition. We report trachyonychia occurring simultaneously in dizygotic twins, further supporting a possible underlying genetic basis of this idiopathic nail disorder.


Subject(s)
Nail Diseases , Nails, Malformed , Genetic Predisposition to Disease , Humans , Nail Diseases/diagnosis , Nail Diseases/genetics , Nails , Nails, Malformed/diagnosis , Nails, Malformed/genetics , Twins, Dizygotic/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...